- Raised $6.1M Series B led by Corteva, Jan 2025
- Raised $3.9M Series C led by Corteva, Oct 2025
- Raised $500k Seed round led by Bayer Trendlines Ag Innovation Fund, Mar 2017
About
IBI-Ag is an Israeli crop protection company specializing in bioinsecticides. It develops next-generation biological solutions for insect control using Single Domain Antibodies (SDAs) — nanobodies around ten times smaller than conventional antibodies. These ultra-specific molecules bind to key proteins in insect digestive systems, disrupting essential processes and leading to natural pest mortality. The company's technology aims to provide effective pest control in a sustainable way, offering alternatives to conventional methods that protect yields while reducing synthetic inputs. IBI-Ag's products are designed to be highly stable across different environments and field conditions, with a low ecological footprint. The company has also successfully completed a proof of concept for an AI-driven platform for de novo design of novel bioinsecticide proteins.
Funding history · 7 rounds · $10.5M total
Headcount over time
Q&A
- What is IBI-Ag's primary focus?
- IBI-Ag is an Israeli crop protection company that develops natural single domain antibody insecticides to increase crop production sustainably, without harm to farmers, consumers, or the environment.
- How many employees does IBI-Ag currently have?
- IBI-Ag has 19 employees, falling within the 11-50 employee bucket.
- What was IBI-Ag's most recent funding round?
- In November 2025, IBI-Ag completed a $10 million Series A round. Key investors included Corteva Agriscience and The Trendlines Group.
- What was the amount of IBI-Ag's Series A funding round in February 2025?
- In February 2025, IBI-Ag raised $6.1 million in a Series A funding round. Investors included Corteva and The Trendlines Group.
- What is IBI-Ag's core technology?
- IBI-Ag develops next-generation biological solutions for insect control using Single Domain Antibodies (SDAs), which are ultra-specific nanobodies that disrupt essential processes in insect digestive systems.
- Has IBI-Ag received any grants recently?
- Yes, in November 2025, IBI-Ag received a grant of $3.9 million from Corteva.
- Who are the co-founders of IBI-Ag?
- The co-founders of IBI-Ag are Amir Ayali, PhD, and Rony Oren Benaroya, PhD.
Team · 2
Sectors & technology
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | ibi-ag.com/ |
|---|---|
| linkedin.com/company/42172406 |
Identifiers & details
| Legal name | ibi-ag innovative bio insecticides ltd |
|---|---|
| Founded | 2017 |
| Employees (exact) | 19 |
Radar intelligence
Patents
| EPO | 143 |
|---|
Web history (Wayback)
| Domain | ibi-ag.com |
|---|
Certificate / subdomain footprint
| Subdomains | 1 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 515646578 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2017-04-23 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | yes |
| Last annual report | 2023 |
| Active charges / liens | 0 |
| Registry events | 8 — other (1), violation (1), shares_capital (3), charge (1), people (2) |
| Registered address | אין רחובות 17 משגב |
Recent registry events
| Date | Event |
|---|---|
| 2025-11-25 | שינוי בתקנון |
| 2026-06-25 | עדכון הפרה |
| 2025-11-24 | הגדלה של הון רשום |
| 2025-10-23 | סילוק שעבוד |
| 2026-04-20 | הקצאת מניות |
| 2026-04-19 | העברת מניות |
| 2025-12-11 | עדכון בעלי תפקידים |
| 2026-02-08 | עדכון דירקטורים-הוספת דירקטור |